Clinical Trial Update: A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Obutinib or Decitabine in combination with Rituximab, Cyclophosphamide, and Prednisone as the primary therapy for elderly …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Decitabine (Decitabine)
• Obutinib
• PREDNISONE (Prednisone)
• Rituximab (rituximab)

Snippet

Sponsor: Mingzhi Zhang | Conditions: Newly Diagnosed Diffuse Large B-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING